Granules India Limited
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- ₹68.22 billion
- Book Value:
- Revenue TTM:
- ₹45.12 billion
- Operating Margin TTM:
- Gross Profit TTM:
- ₹22.18 billion
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Granules India Limited had its IPO on under the ticker symbol GRANULES.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Granules India Limited has a staff strength of 0 employees.
Shares of Granules India Limited opened at ₹278 at the start of the last trading session i.e. 2023-05-30.
The stocks traded within a range of ₹276.85 - ₹282.35, and closed at ₹281.35.
This is a +1.63% increase from the previous day's closing price.
A total volume of 738,128 shares were traded at the close of the day’s session.
In the last one week, shares of Granules India Limited have increased by +1.83%.
Granules India Limited's Key Ratios
Granules India Limited has a market cap of ₹68.22 billion, indicating a price to book ratio of 3.2099 and a price to sales ratio of 2.009.
In the last 12-months Granules India Limited’s revenue was ₹45.12 billion with a gross profit of ₹22.18 billion and an EBITDA of ₹9.14 billion. The EBITDA ratio measures Granules India Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Granules India Limited’s operating margin was 16.16% while its return on assets stood at 9.68% with a return of equity of 19.06%.
In Q1, Granules India Limited’s quarterly earnings growth was a positive 10.3% while revenue growth was a positive 16.1%.
Granules India Limited’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at ₹20.99 per share while it has a forward price to earnings multiple of 15.4083 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Granules India Limited’s profitability.
Granules India Limited stock is trading at a EV to sales ratio of 2.1282 and a EV to EBITDA ratio of 10.6939. Its price to sales ratio in the trailing 12-months stood at 2.009.
Granules India Limited stock pays annual dividends of ₹1.5 per share, indicating a yield of 0.54% and a payout ratio of 4.67%.
Balance sheet and cash flow metrics
- Total Assets
- ₹49.05 billion
- Total Liabilities
- ₹18.14 billion
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Granules India Limited ended 2023 with ₹49.05 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹49.05 billion while shareholder equity stood at ₹28.35 billion.
Granules India Limited ended 2023 with ₹0 in deferred long-term liabilities, ₹18.14 billion in other current liabilities, in common stock, ₹0 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹2.92 billion and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹1.49 billion.
Granules India Limited’s total current assets stands at ₹25.74 billion while long-term investments were ₹0 and short-term investments were ₹244.00 million. Its net receivables were ₹9.49 billion compared to accounts payable of ₹7.82 billion and inventory worth ₹11.49 billion.
In 2023, Granules India Limited's operating cash flow was ₹0 while its capital expenditure stood at ₹0.
Comparatively, Granules India Limited paid ₹0.05 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Granules India Limited stock is currently trading at ₹281.35 per share. It touched a 52-week high of ₹381.25 and a 52-week low of ₹381.25. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹290.92 and 200-day moving average was ₹314.87 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4725.4% of the company’s stock are held by insiders while 2122.3% are held by institutions.
Frequently Asked Questions About Granules India Limited
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company’s APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other specialty products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.